Free Trial

Point72 DIFC Ltd Makes New $573,000 Investment in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Guardian Pharmacy Services logo

Point72 DIFC Ltd bought a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 34,098 shares of the company's stock, valued at approximately $573,000. Point72 DIFC Ltd owned approximately 0.05% of Guardian Pharmacy Services as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Stephens Inc. AR purchased a new position in Guardian Pharmacy Services during the third quarter valued at approximately $189,000. Royce & Associates LP bought a new position in Guardian Pharmacy Services in the 3rd quarter valued at $1,260,000. Foundry Partners LLC purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter valued at $1,680,000. Seven Grand Managers LLC bought a new position in shares of Guardian Pharmacy Services in the third quarter worth $2,515,000. Finally, Maven Securities LTD purchased a new stake in shares of Guardian Pharmacy Services in the third quarter worth $3,033,000.

Insider Activity

In related news, Director Steven D. Cosler acquired 7,000 shares of the company's stock in a transaction dated Tuesday, November 19th. The stock was purchased at an average price of $21.22 per share, with a total value of $148,540.00. Following the completion of the purchase, the director now owns 17,713 shares in the company, valued at $375,869.86. This trade represents a 65.34 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the company's stock in a transaction on Friday, September 27th. The shares were purchased at an average cost of $14.00 per share, with a total value of $499,996.00. Following the transaction, the director now directly owns 35,714 shares in the company, valued at $499,996. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here.

Guardian Pharmacy Services Trading Up 1.4 %

Shares of GRDN traded up $0.35 during midday trading on Friday, reaching $25.00. The stock had a trading volume of 228,702 shares, compared to its average volume of 155,810. The business has a 50-day moving average price of $20.04. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $25.57.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. On average, equities research analysts predict that Guardian Pharmacy Services, Inc. will post 0.86 EPS for the current year.

Analyst Upgrades and Downgrades

GRDN has been the subject of several research analyst reports. Stephens began coverage on Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They set an "overweight" rating and a $21.00 target price for the company. Truist Financial boosted their price objective on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a "buy" rating in a report on Friday, November 15th. Finally, Raymond James assumed coverage on shares of Guardian Pharmacy Services in a research note on Monday, October 21st. They issued an "outperform" rating and a $21.00 target price on the stock.

Check Out Our Latest Research Report on GRDN

Guardian Pharmacy Services Profile

(Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

See Also

Institutional Ownership by Quarter for Guardian Pharmacy Services (NYSE:GRDN)

Should you invest $1,000 in Guardian Pharmacy Services right now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Meta Is Still a Top Stock Pick for 2025

Why Meta Is Still a Top Stock Pick for 2025

Meta Platforms continues to shine as one of the strongest AI-driven companies heading into 2025. Learn why Meta is a solid pick for next year.

Related Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
3 Momentum Stock Picks With Room to Run

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines